Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease

IF 11.1 1区 医学 Q1 CLINICAL NEUROLOGY Alzheimer's & Dementia Pub Date : 2025-01-27 DOI:10.1002/alz.14547
Boye Wen, Xiaodong Han, Jin Gong, Pin Wang, Wenxian Sun, Chang Xu, Aidi Shan, Xin Wang, Heya Luan, Shaoqi Li, Ruina Li, Jinxuan Guo, Runqi Chen, Chuqiao Li, Yao Sun, Sirong Lv, Cuibai Wei
{"title":"Nutrition: A non-negligible factor in the pathogenesis and treatment of Alzheimer's disease","authors":"Boye Wen,&nbsp;Xiaodong Han,&nbsp;Jin Gong,&nbsp;Pin Wang,&nbsp;Wenxian Sun,&nbsp;Chang Xu,&nbsp;Aidi Shan,&nbsp;Xin Wang,&nbsp;Heya Luan,&nbsp;Shaoqi Li,&nbsp;Ruina Li,&nbsp;Jinxuan Guo,&nbsp;Runqi Chen,&nbsp;Chuqiao Li,&nbsp;Yao Sun,&nbsp;Sirong Lv,&nbsp;Cuibai Wei","doi":"10.1002/alz.14547","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>Alzheimer's disease (AD) is a degenerative disease characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence and progression of AD pathology has been well documented. Poor nutritional status accelerates AD progress by potentially aggravating amyloid beta (Aβ) and tau deposition, exacerbating oxidative stress response, modulating the microbiota–gut–brain axis, and disrupting blood–brain barrier function. The advanced stage of AD tends to lead to malnutrition due to cognitive impairments, sensory dysfunctions, brain atrophy, and behavioral and psychological symptoms of dementia (BPSD). This, in turn, produces a vicious cycle between malnutrition and AD. This review discusses how nutritional factors and AD deteriorate each other from the early stage of AD to the terminal stages of AD, focusing on the potential of different levels of nutritional factors, ranging from micronutrients to diet patterns. This review provides novel insights into reducing the risk of AD, delaying its progression, and improving prognosis.</p>\n </section>\n \n <section>\n \n <h3> Highlights</h3>\n \n <div>\n <ul>\n \n <li>Two-fifths of Alzheimer's disease (AD) cases worldwide have been attributed to potentially modifiable risk factors.</li>\n \n <li>Up to ≈26% of community-dwelling patients with AD are malnourished, compared to 7%∼76% of institutionalized patients.</li>\n \n <li>Undernutrition effects the onset, progression, and prognosis of AD through multiple mechanisms.</li>\n \n <li>Various levels of nutritional supports were confirmed to be protective factors for AD via specific mechanisms.</li>\n </ul>\n </div>\n </section>\n </div>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"21 2","pages":""},"PeriodicalIF":11.1000,"publicationDate":"2025-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/alz.14547","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.14547","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Alzheimer's disease (AD) is a degenerative disease characterized by progressive cognitive dysfunction. The strong link between nutrition and the occurrence and progression of AD pathology has been well documented. Poor nutritional status accelerates AD progress by potentially aggravating amyloid beta (Aβ) and tau deposition, exacerbating oxidative stress response, modulating the microbiota–gut–brain axis, and disrupting blood–brain barrier function. The advanced stage of AD tends to lead to malnutrition due to cognitive impairments, sensory dysfunctions, brain atrophy, and behavioral and psychological symptoms of dementia (BPSD). This, in turn, produces a vicious cycle between malnutrition and AD. This review discusses how nutritional factors and AD deteriorate each other from the early stage of AD to the terminal stages of AD, focusing on the potential of different levels of nutritional factors, ranging from micronutrients to diet patterns. This review provides novel insights into reducing the risk of AD, delaying its progression, and improving prognosis.

Highlights

  • Two-fifths of Alzheimer's disease (AD) cases worldwide have been attributed to potentially modifiable risk factors.
  • Up to ≈26% of community-dwelling patients with AD are malnourished, compared to 7%∼76% of institutionalized patients.
  • Undernutrition effects the onset, progression, and prognosis of AD through multiple mechanisms.
  • Various levels of nutritional supports were confirmed to be protective factors for AD via specific mechanisms.

Abstract Image

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
营养:阿尔茨海默病发病和治疗过程中不可忽视的因素
阿尔茨海默病(AD)是一种以进行性认知功能障碍为特征的退行性疾病。营养与阿尔茨海默病病理发生和进展之间的密切联系已得到充分证明。不良的营养状况可能会加重β -淀粉样蛋白(Aβ)和tau沉积,加剧氧化应激反应,调节微生物-肠-脑轴,破坏血脑屏障功能,从而加速AD的进展。阿尔茨海默病的晚期往往由于认知障碍、感觉功能障碍、脑萎缩以及痴呆(BPSD)的行为和心理症状而导致营养不良。这反过来又在营养不良和阿尔茨海默病之间产生了恶性循环。本文综述了从阿尔茨海默病早期到终末期,营养因子与阿尔茨海默病相互恶化的过程,重点讨论了从微量营养素到饮食模式等不同水平营养因子的潜在影响。本综述为降低阿尔茨海默病的风险、延缓其进展和改善预后提供了新的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Alzheimer's & Dementia
Alzheimer's & Dementia 医学-临床神经学
CiteScore
14.50
自引率
5.00%
发文量
299
审稿时长
3 months
期刊介绍: Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.
期刊最新文献
The cholinergic system exerts opposing effects on memory at different stages of disease progression in Alzheimer's and Down syndrome model systems The Alzheimer's Disease Diagnosis and Plasma Phospho‐Tau217 (ADAPT) study stage 1: Validating clinical cut‐points against CSF and amyloid PET Factors impacting survival in individuals with Down syndrome-associated Alzheimer's disease Plasma p-tau217 predicts PET-based pathological staging for precision Alzheimer disease assessment Astrocytic PYGM attenuates tau pathology by promoting lactate-mediated neuroprotection
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1